Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Czechia Denmark Italy Portugal Spain +1
  • Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Denmark France Italy Spain Sweden
  • Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany The Netherlands
  • Study on the Effectiveness and Safety of BP1.7881 for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Poland
  • Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Denmark Estonia Finland France +3
  • A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Bulgaria Czechia Germany Poland Spain
  • Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria France Germany Greece +8
  • Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    Belgium Czechia Denmark Estonia Finland Germany +5
  • A study testing TRIV-509 compared to placebo in adults with moderate to severe atopic dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    Bulgaria Czechia Hungary Poland
  • A Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Czechia Germany Poland